
    
      This randomized controlled clinical trial included 52 patients with type 2 diabetes mellitus
      suffering from xerostomia, divided equally into two groups. Group-I was managed by topical
      spray containing 1% malic. Group- II was managed by a placebo spray. Both groups received the
      treatment for 2 weeks. Dry mouth questionnaire scores (DMQ) and unstimulated salivary flow
      rate was collected before and after treatment.
    
  